EVERLIT CARE Triple Antibiotic
EVERLIT CARE Triple Antibiotic is an FDA drug label for the active ingredient BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE manufactured by EVERLIT GLOBAL INC. administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231114.
- Generic name
- BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE
- Manufacturer
- EVERLIT GLOBAL INC.
- Product type
- HUMAN OTC DRUG
- Route
- TOPICAL
- Dosage form
- N/A
- NDC
- 83807-002
- Application
- M004
- Label effective
- 20231114
Active ingredients
Indications & Usage
Uses First aid to help prevent infection in minor cuts, scrapes and burns
Dosage & Administration
Directions Clean and disinfect the affected area Apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily May be covered with a sterile bandage.
Contraindications
Not available.
Warnings
Warnings For external use only.
Adverse Reactions
Not available.